The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Caffeine acts through neuronal adenosine A 2A receptors to prevent mood and memory dysfunction triggered by chronic stress
Open accessAbstract
Significance: Epidemiological studies show that individuals exposed to repeated stress, a major trigger of depression, increase their caffeine intake, which correlates inversely with the incidence of depression. However, the mechanism underlying this protective effect is unknown. We used an animal model of chronic unpredictable stress (CUS) to show that caffeine prevents the maladaptive changes caused by CUS in a manner mimicked by the selective blockade of adenosine A 2A receptors (A 2A R). CUS enhanced A 2A R in synapses, and the selective elimination of neuronal A 2A R abrogated CUS modifications. Moreover, A 2A R blockade also afforded a therapeutic benefit, paving the way to consider A 2A R blockers as a strategy to manage the negative impact of chronic stress on mood and memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, animal experiments have demonstrated that A 2A R are upregulated in chronic stress animal models. 102”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 6×
“Compared with nonstressed (control) mice (noncheckered bars), the mice subjected to CUS (checkered bars) displayed increased immobility in the forced-swimming test [F(2,36) = 182.”
BackgroundResultInfluentialStress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Willner, P. (1997) · Psychopharmacology · doi:10.1007/s002130050456 · Cited by 1,832
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 2×
“However, the data are compatible with A2AR having a key role in glutamatergic terminals defining the synaptic dysfunction underlying the behavioral alterations associated with repeated stress (26, 27).”
The stressed hippocampus, synaptic plasticity and lost memories
Kim, J. J., & Diamond, D. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn849 · Cited by 1,543
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Sousa, N., Lukoyanov, N. V., Madeira, M. D., Almeida, O. F. X., & Paula-Barbosa, M. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00050-6 · Cited by 758
Fredholm, B. B., Chen, J., Cunha, R. A., Svenningsson, P., & Vaugeois, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 721
Self-citationNeuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
Cunha, R. A. (2005) · Purinergic Signalling · doi:10.1007/s11302-005-0649-1 · Cited by 555
Self-citationChronic stress alters synaptic terminal structure in hippocampus
Magariños, A. M., Verdugo, J. M. G., & McEwen, B. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14002 · Cited by 543
Cited by
Sorted by citations
Items 101–200 of 312
Early-life exposure to caffeine affects the construction and activity of cortical networks in mice
Fazeli, W., Zappettini, S., Marguet, S. L., Grendel, J., Esclapez, M., Bernard, C., & Isbrandt, D. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.05.013 · Cited by 33
Dobrachinski, F., Gerbatin, R. R., Sartori, G., Golombieski, R. M., Antoniazzi, A. Q., Nogueira, C. W., Royes, L. F. F., Fighera, M. R., Porciúncula, L. O., Cunha, R. A., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1296-1 · Cited by 33
Self-citationAugusto, E., Gonçalves, F. Q., Real, J. I., Silva, H. B. L., Pochmann, D., Silva, T. S., Matos, M., Gonçalves, N., Tomé, Â. R., Chen, J., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105441 · Cited by 33
Self-citationAdenosine A2A Receptors as Biomarkers of Brain Diseases
Moreira-de-Sá, A., Lourenço, V. S., Canas, P. M., & Cunha, R. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.702581 · Cited by 33
Self-citationOgawa, Y., Furusawa, E., Saitoh, T., Sugimoto, H., Omori, T., Shimizu, S., Kondo, H., Yamazaki, M., Sakuraba, H., & Oishi, K. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.014 · Cited by 34
Activation of adenosine A2A receptors in the olfactory tubercle promotes sleep in rodents
Li, R., Wang, Y., Liu, W., Zhang, M., Li, L., Chérasse, Y., Schiffmann, S. N., d’Exaerde, A. D. K., Lazarus, M., Qu, W., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107923 · Cited by 34
Yang, L., Yu, X., Zhang, Y., Liu, N., Li, D.-N., Xue, X.-D., & Fu, J.-H. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13834 · Cited by 22
Therapeutic Opportunities for Caffeine and A2A Receptor Antagonists in Retinal Diseases
Boia, R., Ambrósio, A. F., & Santiago, A. R. (2016) · Ophthalmic Research · doi:10.1159/000443893 · Cited by 30
Lopes, C. R., Oliveira, A., Gaspar, I. L., Rodrigues, M. S., Santos, J., Szabó, E. C., Silva, H. B. L., Tomé, Â. R., Canas, P. M., Agostinho, P. M., et al. (2023) · Biomolecules · doi:10.3390/biom13010106 · Cited by 29
Self-citationAlzheimer and Purinergic Signaling: Just a Matter of Inflammation?
Merighi, S., Poloni, T. E., Terrazzan, A., Moretti, E., Gessi, S., & Ferrari, D. (2021) · Cells · doi:10.3390/cells10051267 · Cited by 30
Li, X., Hong, F.-F., Tu, Y., Li, Y., Ma, C., Yu, C., Li, F., Chen, J., Li, Z., Bao, S.-J., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113929 · Cited by 29
Self-citationGonçalves, F. Q., MATHEUS, F. C., Silva, H. B. L., Real, J. I., Rial, D., Rodrigues, R. J., Oses, J. P., Silva, A. C., Gonçalves, N., Prediger, R. D., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03162-1 · Cited by 29
Self-citationChen, J., Choi, D., & Cunha, R. A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109421 · Cited by 29
Self-citationLemos, C., Rial, D., Gonçalves, F. Q., Pires, J., Silva, H. B. L., MATHEUS, F. C., Silva, A. C., Marques, J. M., Rodrigues, R. J., Jarak, I., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.018 · Cited by 32
Self-citationReis, S. L., Silva, H. B. L., de Almeida, M. F., Cunha, R. A., Simões, A. P., & Canas, P. M. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14816 · Cited by 28
Self-citationAdenosine and adenosine receptors in metabolic imbalance-related neurological issues
Jang, M., & Song, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116996 · Cited by 30
Ardais, A. P., da Rocha, A. S., Borges, M. F., Fioreze, G. T., Sallaberry, C., Mioranzza, S., Nunes, F., Pagnussat, N., Botton, P. H. S., Cunha, R. A., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.026 · Cited by 29
Self-citationJoung, J. Y., Song, J. G., Kim, H. W., & Oh, N. S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07292 · Cited by 27
Rei, N., Rombo, D. M., Ferreira, M. F., Baqi, Y., Müller, C. E., Ribeiro, J. A., Sebastião, A. M., & Vaz, S. H. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108106 · Cited by 27
Self-citationKonishi, Y., Hori, H., Ide, K., Katsuki, A., Atake, K., Igata, R., Kubo, T., Tominaga, H., Beppu, H., Asahara, T., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202247 · Cited by 26
Xu, B., Lian, S., Guo, J., Wang, J., Zhang, L.-P., Li, S., & Yang, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.028 · Cited by 26
Alçada-Morais, S., Gonçalves, N., Moreno‐Juan, V., Andres, B., Ferreira, S., Marques, J. M., Magalhães, J., Rocha, J. M. M., Xu, X., Partidário, M., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab188 · Cited by 26
Self-citationMerighi, S., Borea, P. A., Varani, K., Vincenzi, F., Travagli, A., Nigro, M., Pasquini, S., Suresh, R. R., Kim, S. W., Volkow, N. D., et al. (2022) · Molecules · doi:10.3390/molecules27092680 · Cited by 27
Colla, A. R. D. S., Pazini, F. L., Lieberknecht, V., Camargo, A., & Rodrigues, A. L. S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00658-4 · Cited by 24
Self-citationPurinergic transmission in depressive disorders
Szopa, A., Socała, K., Serefko, A., Doboszewska, U., Wróbel, A., Poleszak, E., & Właź, P. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107821 · Cited by 25
Caffeine is negatively associated with depression in patients aged 20 and older
Bao, J., Li, P., Guo, Y., Zheng, Y., Smolinski, M., & He, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1037579 · Cited by 29
Botsakis, K., Mourtzi, T., Panagiotakopoulou, V., Vreka, M., Stathopoulos, G. T., Pediaditakis, I., Charalampopoulos, I., Gravanis, A., Delis, F., Antoniou, K., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.043 · Cited by 25
Leffa, D. T., Pandolfo, P., Gonçalves, N., Machado, N. J., de Souza, C. M., Real, J. I., Silva, A. C., Silva, H. B. L., Köfalvi, A., Cunha, R. A., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00475 · Cited by 25
Self-citationMachado, D. G., de Lara, M. V. S., Dobler, P. B., Almeida, R. F., & Porciúncula, L. O. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109776 · Cited by 25
Self-citationLin, Y.-S., Weibel, J., Landolt, H., Santini, F., Slawik, H. C., Borgwardt, S., Cajochen, C., & Reichert, C. (2023) · Scientific Reports · doi:10.1038/s41598-022-26808-5 · Cited by 33
Hall, S., Arora, D. S., Anoopkumar‐Dukie, S., & Grant, G. D. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03568 · Cited by 23
Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection
Karuppagounder, S. S., Uthaythas, S., Govindarajulu, M., Ramesh, S., Parameshwaran, K., & Dhanasekaran, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105066 · Cited by 26
Yoshihara, T., Zaitsu, M., Shiraishi, F., Arima, H., Takahashi‐Yanaga, F., Arioka, M., Kajioka, S., & Sasaguri, T. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.01.006 · Cited by 21
Fuzik, J., Rehman, S., Girach, F., Miklosi, A. G., Korchynska, S., Arqué, G., Romanov, R. A., Hanics, J., Wagner, L., Meletis, K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904006116 · Cited by 20
Dias, L., Pochmann, D., Lemos, C., Silva, H. B. L., Real, J. I., Gonçalves, F. Q., Rial, D., Gonçalves, N., Simões, A. P., Ferreira, S. G., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00810 · Cited by 21
Self-citationCordycepin improves behavioral‐LTP and dendritic structure in hippocampal CA1 area of rats
Han, Y., Chen, Z., Shang, Y., Yan, W., Wu, B., & Li, C. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14826 · Cited by 20
Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer's disease
Ribeiro, D. E., Petiz, L. L., Glaser, T., Oliveira‐Giacomelli, Á., Andrejew, R., Saab, F. D. A. R., Milanis, M. D. S., Campos, H. C., Arnaud-Sampaio, V. F., de Oliveira, S. L. B., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109371 · Cited by 21
Reed, R. A., Mitchell, E. S., Saunders, C., & O’Connor, P. J. (2018) · Journal of Cognitive Enhancement · doi:10.1007/s41465-018-0118-8 · Cited by 20
The neurobiological mechanisms and therapeutic prospect of extracellular ATP in depression
Wang, K., Huang, S., Fu, D., Yang, X., Ma, L., Zhang, T., Zhao, W., Deng, D., Ding, Y., Zhang, Y., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14536 · Cited by 19
Purinergic-associated immune responses in neurodegenerative diseases
Carracedo, S., Launay, A., Déchelle-Marquet, P.-A., Faivre, É., Blum, D. L., Delarasse, C., & Boué‐Grabot, É. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102693 · Cited by 20
Leem, Y., Jang, J.-H., Park, J., & Kim, H.-S. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.06.005 · Cited by 19
Moretti, M., Werle, I., da Rosa, P. B., Neis, V. B., Platt, N., Souza, S. V. D. S., & Rodrigues, A. L. S. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172800 · Cited by 19
Self-citationChung, Y.-S., Choo, B. K. M., Ahmed, P. K., Othman, I., & Shaikh, M. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00692 · Cited by 21
Pereira, M. F., Amaral, I. M., Lopes, C. R., Leitão, C., Madeira, D., Lopes, J. P., Gonçalves, F. Q., Canas, P. M., Cunha, R. A., & Agostinho, P. M. (2021) · The FASEB Journal · doi:10.1096/fj.202100336r · Cited by 18
Self-citationDias, L., Madeira, D., Dias, R., Tomé, Â. R., Cunha, R. A., & Agostinho, P. M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04492-y · Cited by 19
Self-citationIllés, P., Rubini, P., Ulrich, H., Yin, H., & Tang, Y. C. (2025) · MedComm · doi:10.1002/mco2.70177 · Cited by 18
Periodical reactivation under the effect of caffeine attenuates fear memory expression in rats
Pedraza, L. K., Sierra, R. O., Lotz, F. N., & Alvares, L. D. O. (2018) · Scientific Reports · doi:10.1038/s41598-018-25648-6 · Cited by 19
Simões-Henriques, C. F., Mateus‐Pinheiro, M., Gaspar, R., Pinheiro, H., Duarte, J. M., Baptista, F. I., Canas, P. M., Ribeiro, C., Cunha, R. A., Ambrósio, A. F., et al. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14561 · Cited by 21
Self-citationIbrahim, M. K., Kamal, M., Tikamdas, R., Nouh, R. A., Tian, J., & Sayed, M. (2020) · Behavior Genetics · doi:10.1007/s10519-020-10003-1 · Cited by 18
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
Merighi, S., Poloni, T. E., Pelloni, L., Pasquini, S., Varani, K., Vincenzi, F., Borea, P. A., & Gessi, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.652455 · Cited by 18
Akbari, A., Khalili-Fomeshi, M., Ashrafpour, M., Moghadamnia, A. A., & Ghasemi‐Kasman, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.007 · Cited by 18
Wang, M., Song, Y., Wu, D., Li, H., Li, Z., Xiong, X.-X., Hu, N.-Y., Hu, J., Li, J., Wang, Y.-X., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107798 · Cited by 23
Neuroprotective and MAOB inhibitory effects of a series of caffeine-8-thioglycolic acid amides
Kasabova-Angelova, A., Kondeva-Burdina, M., Mitkov, J., Georgieva, M., Tzankova, V. I., & Zlatkov, A. (2020) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902019000318255 · Cited by 18
Esmaili, Z., SoukhakLari, R., Moezi, L., Pirsalami, F., Farrokhi, M. R., Khalaf, N., Kazerouni, A., & Moosavi, M. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.02.007 · Cited by 17
Li, Y., Pan, X., He, Y., Ruan, Y., Huang, L., Zhou, Y., Hou, Z., He, C., Wang, Z., Zhang, X., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00393 · Cited by 17
Self-citationUse of knockout mice to explore CNS effects of adenosine
Lopes, C. R., Lourenço, V. S., Tomé, Â. R., Cunha, R. A., & Canas, P. M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114367 · Cited by 19
Self-citationBartoli, F., Clerici, M., & Carrà, G. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0057-x · Cited by 16
Moreira-de-Sá, A., Gonçalves, F. Q., Lopes, J. P., Silva, H. B. L., Tomé, Â. R., Cunha, R. A., & Canas, P. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105137 · Cited by 16
Self-citationZhu, X.-X., Ma, Q., Yang, F., Li, X., Liu, Y., Chen, J., Li, L., Chen, M., Zou, X., Yan, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.897436 · Cited by 16
Self-citationAged mice receiving caffeine since adulthood show distinct patterns of anxiety-related behavior
Botton, P. H. S., Pochmann, D., da Rocha, A. S., Nunes, F., Almeida, A. S., Marques, D. M., & Porciúncula, L. O. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.11.030 · Cited by 16
Self-citationGenetic tagging of the adenosine A2A receptor reveals its heterogeneous expression in brain regions
Wang, M., Li, Z., Song, Y., Sun, Q., Deng, L., Lin, Z., Zeng, Y., Qiu, C., Lin, J., Guo, H., et al. (2022) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2022.978641 · Cited by 14
Self-citationThebromine Targets Adenosine Receptors to Control Hippocampal Neuronal Function and Damage
Valada, P., Alçada-Morais, S., Cunha, R. A., & Lopes, J. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810510 · Cited by 15
Self-citationSimões, A. P., Gonçalves, F. Q., Rial, D., Ferreira, S. G., Lopes, J. P., Canas, P. M., & Cunha, R. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112826 · Cited by 15
Self-citationImpact of Coffee Intake on Measures of Wellbeing in Mice
Machado, N. J., Ardais, A. P., Nunes, A., Szabó, E. C., Silveirinha, V., Silva, H. B. L., Kaster, M. P., & Cunha, R. A. (2024) · Nutrients · doi:10.3390/nu16172920 · Cited by 16
Self-citationKnowledge and consumption of caffeinated products by university students in Beirut, Lebanon
Khalil, M., & Antoun, J. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.02.014 · Cited by 15
Miao, Y., Chen, X., You, F., Jia, M., Li, T., Tang, P., Shi, R., Hu, S., Zhang, L., Chen, J., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108806 · Cited by 18
Self-citationYang, C., Ni, H., Yin, J.-J., Zhou, T., Gu, Q., Chen, T., & Cai, C.-Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.034 · Cited by 16
Camargo, A., Bettio, L. E. B., da Rosa, P. B., Rosa, J. M., Altê, G. A., & Rodrigues, A. L. S. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09898-8 · Cited by 15
Self-citationFrick, A., Persson, J., & Bodén, R. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211058975 · Cited by 14
Madeira, D., Lopes, C. R., Simões, A. P., Canas, P. M., Cunha, R. A., & Agostinho, P. M. (2023) · Glia · doi:10.1002/glia.24384 · Cited by 14
Self-citationMadeira, D., Domingues, J., Lopes, C. R., Canas, P. M., Cunha, R. A., & Agostinho, P. M. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04983-6 · Cited by 16
Self-citationÜnsal, S., & Şanlıer, N. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00616-5 · Cited by 21
Moreira-de-Sá, A., Gonçalves, F. Q., Lopes, J. P., Silva, H. B. L., Tomé, Â. R., Cunha, R. A., & Canas, P. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02275-9 · Cited by 15
Self-citationZhao, Y., Zhang, H., Zhang, Y., Fang, Z., & Xu, C. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00167 · Cited by 14
Queiroz, L. Y., de Oliveira, I. G., Cartágenes, S. D. C., Fernandes, L. M. P., dos Santos, S. M., Ferreira, W. A. S., Mello, F. A. R., Bittencourt, L. O., Paiva, E. B. C., Burbano, R. M. R., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7207755 · Cited by 14
Ren, L., Zhang, H., Tao, W., Xue, W., Yin, C., Zou, Z., Guo, X., Shen, Q., Wang, W., Jiang, H., et al. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102350 · Cited by 13
Lopes, C. R., Silva, A. C., Silva, H. B. L., Canas, P. M., Agostinho, P. M., Cunha, R. A., & Lopes, J. P. (2023) · Biomolecules · doi:10.3390/biom13081173 · Cited by 13
Self-citationTowers, A. E., Oelschlager, M. L., Lorenz, M. R., Gainey, S. J., McCusker, R. H., Krauklis, S. A., & Freund, G. G. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.025 · Cited by 14
Flores, N. P., Bona, N. P., Luduvico, K. P., Cardoso, J. D. S., Soares, M. S. P., Gamaro, G. D., Spanevello, R. M., Lencina, C. L., Gazal, M., & Stefanello, F. M. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13442 · Cited by 15
Begdache, L., & Patrissy, C. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050435 · Cited by 13
Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease
Kasabova-Angelova, A., Tzankova, D., Mitkov, J., Georgieva, M., Tzankova, V., Zlatkov, A., & Kondeva-Burdina, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180821153316 · Cited by 13
Launay, A., Carvalho, K., Génin, A., Gauvrit, T., Nobili, P., Gómez‐Murcia, V., Augustin, E., Burgard, A., Gambi, J., Fourmy, D., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03115-9 · Cited by 15
Gomaa, A. A., Farghaly, H. S. M., Ahmed, A. M., El‐Mokhtar, M. A., & Hemida, F. K. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174873 · Cited by 12
Kong, Y., Liu, C., Zhang, C., Wang, W., Li, Y., Qiu, H., Wang, G.-M., Li, D., Chen, X., Lv, Z., et al. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s368471 · Cited by 12
Self-citationCaffeine: a potential mechanism for anti-obesity
Wang, M., Guo, W. Y., & Chen, J. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10022-1 · Cited by 13
Self-citationDias, L., Nabais, A. M., Borges-Martins, V. P. P., Canas, P. M., Cunha, R. A., & Agostinho, P. M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16299 · Cited by 12
Self-citationFrança, A. P., Takahashi, R. N., Cunha, R. A., & Prediger, R. D. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0016 · Cited by 13
Self-citationThe striatum drives the ergogenic effects of caffeine
Alves, A. C. D. B., Speck, A. E., Farias, H. R., Martins, L. M., Santos, N. D. S., Pannata, G., Tavares, A. P., de Oliveira, J., Tomé, Â. R., Cunha, R. A., et al. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09922-5 · Cited by 16
Self-citationLind, S. F., Stam, F., Zelleroth, S., Meurling, E., Frick, A., & Grönbladh, A. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173573 · Cited by 12
Purinergic modulation of glutamate transmission: An expanding role in stress-linked neuropathology
Mayhew, J., Graham, B. A., Biber, K. P. H., Nilsson, M., & Walker, F. R. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.023 · Cited by 13
Signaling by adenosine receptors—Homeostatic or allostatic control?
Cunha, R. A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000213 · Cited by 12
Self-citationZhong, Z., Dong, H., Zhou, S., Lin, C., Huang, P., Li, X., Zhang, J., Xie, J., Wu, Y., & Li, P. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70134 · Cited by 11
Mallozzi, C., Pepponi, R., Visentin, S., Chiodi, V., Lombroso, P. J., Bäder, M., Popoli, P., & Domenici, M. R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14866 · Cited by 11
Olopade, F. E., Femi-Akinlosotu, O. M., Adekanmbi, A. J., Ighogboja, O. O., & Shokunbi, M. T. (2021) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2020.0017 · Cited by 11
Markova, E. V., Knyazheva, M. A., Tikhonova, M. A., & Amstislavskaya, T. G. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136790 · Cited by 11
Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson’s disease
Waggan, I., Rissanen, E., Tuisku, J., Joutsa, J., Helin, S., Parkkola, R. K., Rinne, J. O., & Airas, L. M. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11342-1 · Cited by 11
Dziubina, A., Szmyd, K., Zygmunt, M., Sapa, J., Dudek, M., Filipek, B., Drabczyńska, A., Załuski, M., Pytka, K., & Kieć‐Kononowicz, K. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.07.008 · Cited by 11
Zaki, M. G., Jakova, E., Pordeli, M., Setork, E., Taghibiglou, C., & Cayabyab, F. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125680 · Cited by 11
Neis, V. B., Werle, I., Moretti, M., da Rosa, P. B., Camargo, A., Dalsenter, Y. D. O., Platt, N., Rosado, A. F., Engel, W. D., de Almeida, G. R. L., et al. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00979-6 · Cited by 10
Self-citationOthman, M. A., Fadel, R. A., Tayem, Y. I., Jaradat, A., Rashid, A., Fatima, A., Al‐Mahameed, A. E., & El‐Din, W. A. N. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03735-5 · Cited by 10
Metadata
- Authors
- Kaster, M. P., Machado, N. J., Silva, H. B., Nunes, A., Ardais, A. P., Santana, M., Baqi, Y., Müller, C. E., Rodrigues, A. L. S., Porciúncula, L. O., Chen, J. F., Tomé, Â. R., Agostinho, P., Canas, P. M., & Cunha, R. A.
- Affiliations
- Universidade Federal de Santa Catarina (BR)
- Centro de Neurociências e Biologia Celular (PT)
- Universidade Federal do Rio Grande do Sul (BR)
- University of Bonn (DE)
- Boston University (US)
- University of Coimbra (PT)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-06-08
- Volume
- 112
- Issue
- 25
- Pages
- 7833-7838
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4485143
- OpenAlex
- W1591120748
- Cited by
- 312
- References
- 48
- Citations by year
- 2026: 24 · 2025: 28 · 2024: 23 · 2023: 26 · 2022: 33 · 2021: 36 · 2020: 26 · 2019: 29 · 2018: 41 · 2017: 19 · 2016: 17 · 2015: 10
- FWCI
- 13.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Brain and Behavior Research Foundation (2014 NARSAD INDEPENDENT INVESTIGATOR GRANT)
- DOD | Defense Advanced Research Projects Agency (W911NF-10-1-0059)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, adenosine A2A receptor, chronic unpredictable mild stress, depression, anxiety, memory impairment, hippocampus, synaptic plasticity, glutamatergic terminals, SNAP-25, syntaxin, VGLUT1, adenosine A2A receptor antagonists, neuroprotection
- MeSH terms
- Animals, Caffeine, Male, Memory Disorders, Mice, Inbred C57BL, Neurons, Stress, Psychological, Mood Disorders, Receptor, Adenosine A2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review